Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease targets that are difficult to address with any other modality. Triana’s drug discovery engine is powered by high-resolution structural insights, state-of-the-art in silico tools, and bespoke chemical libraries. The research team has validated thebest-in-class platform and initiated multiple programs across different disease areas.

Therapeutics

Biotechnology

TRIANA Biomedicines

Patrick Trojer

Christine Petersen (Wenzel)

Andrew Conery

Vito Palombella

Brenda Sousa

Karen Valentine

Tim Wigle

Daniel La

Kathleen Seyb

Reza Mazhari

Jesse Chen

The Research and Development team at TRIANA Biomedicines is responsible for pioneering the design and optimization of innovative molecular glue therapies. This multi-disciplinary group conducts high-level research to explore difficult disease targets, utilizing advanced structural insights and computational tools to deliver promising drug candidates. By leveraging their expertise across various scientific disciplines, the team drives the progression of multiple drug discovery programs aimed at transforming treatment options in oncology and other challenging disease areas.

Research and Development

Biology and Chemistry Functions

Leadership Team

Research and Development

About

Team members

Other teams at TRIANA Biomedicines

Biology and Chemistry Functions

Leadership Team